日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer.

局部应用 TLR7 激动剂和放射疗法治疗转移性乳腺癌患者

Adams Sylvia, Demaria Sandra, Rinchai Darawan, Wang Ena, Novik Yelena, Oratz Ruth, Fenton-Kerimian Maria, Levine Pascale G, Li Xiaochun, Marincola Francesco, Jin Ping, Stroncek David, Goldberg Judith, Bedognetti Davide, Formenti Silvia Chiara

Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study

评估新诊断为激素受体阳性乳腺癌的绝经后女性与健康女性的肠道微生物群和性激素水平:一项前瞻性病例对照研究

Kwa, Maryann; Hussey, Grant; Novik, Yelena; Franke, Adrian A; Volkova, Angelina; Flores, Karina; Blaser, Martin J; Speyer, James; Oratz, Ruth; Meyers, Marleen; Jhaveri, Komal; Fadel, Ezeddin; Heguy, Adriana; Schluter, Jonas; Ruggles, Kelly V; Adams, Sylvia

Antisemitism in Medicine: An International Perspective

医学领域的反犹主义:国际视角

Gordon, Michael; Teitel, Jerome; Rosenberg, Ted; Oratz, Ruth; Katz, Naomi; Katz, David

Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic

COVID-19 大流行期间接受化疗、生物疗法、内分泌疗法或积极监测的乳腺癌患者的治疗结果

Marks, Douglas K; Budhathoki, Nibash; Kucharczyk, John; Fa'ak, Faisal; D'Abreo, Nina; Kwa, Maryann; Plasilova, Magdalena; Dhage, Shubhada; Soe, Phyu Phyu; Becker, Daniel; Hindenburg, Alexander; Lee, Johanna; Winner, Megan; Okpara, Chinyere; Daly, Alison; Shah, Darshi; Ramdhanny, Angela; Meyers, Marleen; Oratz, Ruth; Speyer, James; Novik, Yelena; Schnabel, Freya; Jones, Simon A; Adams, Sylvia

Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer

糖尿病及其他临床和社会人口学因素与乳腺癌指南一致性治疗的关联

Gold, Heather T; Shao, Huibo; Oratz, Ruth; Yu, Onchee; Hammer, Marilyn; Richardson, Stephen; Boudreau, Denise

Diabetes and differences in detection of incident invasive breast cancer

糖尿病与新发浸润性乳腺癌检测的差异

Calip, Gregory S; Yu, Onchee; Boudreau, Denise M; Shao, Huibo; Oratz, Ruth; Richardson, Stephen B; Gold, Heather T

Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer

医生调查21基因复发评分检测结果对淋巴结阳性、雌激素受体阳性乳腺癌患者治疗建议的影响

Oratz, Ruth; Kim, Benjamin; Chao, Calvin; Skrzypczak, Stanley; Ory, Caron; Bugarini, Roberto; Broder, Michael

Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors

一项针对难治性非血液肿瘤患者的 I 期研究,评估蛋白激酶 C 调节剂 bryostatin 1 在顺铂治疗前的疗效。

Pavlick, Anna C; Wu, Jennifer; Roberts, John; Rosenthal, Mark A; Hamilton, Anne; Wadler, Scott; Farrell, Kathleen; Carr, Michelle; Fry, David; Murgo, Anthony J; Oratz, Ruth; Hochster, Howard; Liebes, Leonard; Muggia, Franco

Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer

商业参考实验室检测复发评分对早期乳腺癌决策的影响

Oratz, Ruth; Paul, Dev; Cohn, Allen L; Sedlacek, Scot M